These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28692640)

  • 41. Short report: neonatal screening pilot study of Toxoplasma gondii congenital infection in Mexico.
    Vela-Amieva M; Cañedo-Solares I; Gutiérrez-Castrellón P; Pérez-Andrade M; González-Contreras C; Ortíz-Cortés J; Ortega-Velázquez V; Galván-Ramírez Mde L; Ruiz-García M; Saltigeral-Simentel P; Ordaz-Favila JC; Sánchez C; Correa D
    Am J Trop Med Hyg; 2005 Feb; 72(2):142-4. PubMed ID: 15741549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toxoplasmosis.
    Petersen E
    Semin Fetal Neonatal Med; 2007 Jun; 12(3):214-23. PubMed ID: 17321812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Results of a preventive program for congenital toxoplasmosis.
    Ghidini A; Sirtori M; Spelta A; Vergani P
    J Reprod Med; 1991 Apr; 36(4):270-3. PubMed ID: 2072359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
    Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
    Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical validation of a western blot assay for congenital toxoplasmosis and newborn screening in a hospital in Armenia (Quindio) Colombia.
    Gallego-Marín C; Henao AC; Gómez-Marín JE
    J Trop Pediatr; 2006 Apr; 52(2):107-12. PubMed ID: 16014760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen?
    Gilbert RE; Peckham CS
    J Med Screen; 2002; 9(3):135-41. PubMed ID: 12370327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Official recommendations and strategy for prevention of congenital toxoplasmosis in Germany.
    Janitschke K
    Arch Pediatr; 2003 Feb; 10 Suppl 1():15. PubMed ID: 12802956
    [No Abstract]   [Full Text] [Related]  

  • 48. Preventing congenital toxoplasmosis.
    Lopez A; Dietz VJ; Wilson M; Navin TR; Jones JL
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):59-68. PubMed ID: 15580732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Should a preventive congenital toxoplasmosis program be established in Switzerland?].
    Raeber PA
    Schweiz Med Wochenschr Suppl; 1995; 65():5S-9S. PubMed ID: 7716453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
    Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
    Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness analysis of the national Perinatal Hepatitis B Prevention Program.
    Barbosa C; Smith EA; Hoerger TJ; Fenlon N; Schillie SF; Bradley C; Murphy TV
    Pediatrics; 2014 Feb; 133(2):243-53. PubMed ID: 24394684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Toxoplasmosis screening: tu felix Austria?].
    Seitz HM
    Wien Klin Wochenschr; 1997 Sep; 109(16):621-2. PubMed ID: 9412083
    [No Abstract]   [Full Text] [Related]  

  • 53. [Management of congenital toxoplasmosis in France: current data].
    Garcia-Méric P; Franck J; Dumon H; Piarroux R
    Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxoplasmosis: will the time ever come?
    Pedreira DA; Camargo ME; Leser PG
    Ultrasound Obstet Gynecol; 2001 Jun; 17(6):459-63. PubMed ID: 11422964
    [No Abstract]   [Full Text] [Related]  

  • 55. [Toxoplasmosis screening of pregnant patients in Austria].
    Coradello H; Thalhammer O
    Z Geburtshilfe Perinatol; 1984; 188(5):197-200. PubMed ID: 6506831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevention of congenital toxoplasmosis in a Buenos Aires hospital].
    Carral L; Kaufer F; Olejnik P; Freuler C; Durlach R
    Medicina (B Aires); 2013; 73(3):238-42. PubMed ID: 23732199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
    Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
    Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening methods for congenital toxoplasma and risk of disease.
    Lynfield R; Hsu HW; Guerina NG
    Lancet; 1999 Jun; 353(9168):1899-900. PubMed ID: 10371564
    [No Abstract]   [Full Text] [Related]  

  • 59. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Congenital toxoplasmosis: epidemiologic features and control.
    Carter AO; Frank JW
    CMAJ; 1986 Sep; 135(6):618-23. PubMed ID: 3756692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.